 | Up a level |
O'Hara, Daniel Vincent and Bassi, Abhinav and Wilcox, Arlen and Jha, Vivekanand and Rathore, Vinay and D'Cruz, Sanjay and Snelling, Thomas L. and Jones, Mark and Totterdell, James and Bangi, Ashpak and Jain, Manish Kumar and Pollock, Carol and Burrell, Louise and Fox, Gregory and Jones, Cheryl and Kotwal, Sradha and Omar, Sharifah Faridah Syed and Jardine, Meg and CLARITY 2 0 trial investigators, - (2024) Combination of the chemokine receptor type 2 (CCR2) antagonist DMX-200 and candesartan for COVID-19: a randomised controlled trial. BMJ Open, 14 (10). e081790. ISSN 2044-6055, DOI https://doi.org/10.1136/bmjopen-2023-081790.
Oshima, Megumi and Jardine, Meg J. and Agarwal, Rajiv and Bakris, George and Cannon, Christopher P. and Charytan, David M. and de Zeeuw, Dick and Edwards, Robert and Greene, Tom and Levin, Adeera and Lim, Soo Kun and Mahaffey, Kenneth W. and Neal, Bruce and Pollock, Carol and Rosenthal, Norman and Wheeler, David C. and Zhang, Hong and Zinman, Bernard and Perkovic, Vlado and Heerspink, Hiddo J. L. (2021) Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice. Kidney International, 99 (4). pp. 999-1009. ISSN 0085-2538, DOI https://doi.org/10.1016/j.kint.2020.10.042.
Khoo, Chin Meng and Deerochanawong, Chaicharn and Chan, Siew Pheng and Matawaran, Bien and Sheu, Wayne Huey-Herng and Chan, Juliana and Mithal, Ambrish and Luk, Andrea and Suastika, Ketut and Yoon, Kun-Ho and Ji, Linong and Man, Nguyen Huu and Pollock, Carol (2021) Use of sodium-glucose co-transporter-2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations. Diabetes Obesity & Metabolism, 23 (2). pp. 299-317. ISSN 1462-8902, DOI https://doi.org/10.1111/dom.14251.
